Ramos SO, González MM, Rojas GC, Borroto MY, Hernández CT

Language: Spanish
References: 12
Page:
PDF size: 51.65 Kb.

ABSTRACT

The case of a black patient, female, 2 years old with previous history of health is presented. She came to emergency department of General Teaching Hospital of Moron "Roberto Rodriguez Fernandez" for presenting an abscess in the right posterolateral side of the right thigh, the patient was announced for incision and drainage. The patient arrived to the Surgery Room with deep venous approach in the left femoral, conscious, tearful. She was moved to the Operating Room and it was decided General Inhalation Anesthesia with halothane, previous monitoring of cardiovascular function with DOCTUS VI, she fall slept with that halogen at 5% and 3l min of O₂, once we reached to the hypnosis, it was reduced at 2% and kept to this percent, the surgery time was 10 min, at the end of the surgery, the girl began with fasciculations and rigidity of the upper and lower limbs in flexion, a sudden increase of body temperature, was kept the spontaneous ventilation all the time, quickly it was proceed to make differential diagnosis and it was diagnosed as Malignant Hyperthermia, Anesthetic Fever or Malignant Fever.

REFERENCES

1. Churchill-Davidson HC, Wylie WD. Anestesiología. La Habana: Científico-Técnica; 2010.

2. Thornton JA. Trastornos neurológicos y musculares. En: Cecil Gray T, Nunn JF,Utting JE. Anestesia General. La Habana: Científico-Técnica, 2012; t2:823-5.

3. Allen GC. Malignant hyperthermia and associated disorders. Curr Opin Reumatol 2007; 5(6):719-24.

4. O´Flynn RP, Shutack JG, Rosenberg H, Fletcher JE. Masseter muscle rigidity and malignant, 2008. Bichel T, Canivet JL, Damas P, Lamy M. Malignant hyperthermia and severe hypoglicemia after reexposure to halothane. Acta Anaesthesiol Belg. 2009; 45(1):23-7.

5. Merli GJ, Bell RD. Tratamiento preoperatorio del paciente quirúrgico con enfermedad neurológica. Consulta Preoperatoria. Clin Med Norteam. 2011; 71:516-17.

6. Romero NB, Nivoche Y, Lunardi J, Bruneau B, Cheval MA, Hillaide D, et al. Malignant hyperthermia and central core disease: analysis of two families with heterogeneous clinical expression. Neuromuscul Disord. 2011; 3(5-6):547-51.

7. Raines D, Chang SP, Patafio O. Problemas intraanestésicos. En: Davinson JK, Eckhardt WF, Perese DA. Procedimientos de anestesia clínica del Massachusetts General Hospital. 2 ed. Barcelona: Masson-Little Brown; 2009: 232-54.

8. Prielipp RC, Coursin DB. Applied pharmacology of common neuromuscular blocking agents in critical care. New Horizons. 2008; 1(2):34-47.

9. Semmler A, Rieger C, Lesinski R. A case report of malignant hyperthermia in a 14 month old boy. Anesthesiol Reanim. 2009; 19(1):21-2.

10. Rosenberg H, Seilman D, Fletcher J. Certain inherited disorders enhanced or instigated by drug administered by anestesiologist. En: Barash PG, Cullen BF, Stoelting RK. Clin Anesth. Philadelphia: JB Lippincott, 2012. p.589-613.

11. Instantáneas. Síndrome de la hipertermia maligna. Med Interam. 2010; 16(7):412-3.

12. Merino C. Indicaciones, contraindicaciones y criterios de elección de los anestésicos halogenados. En: Actualizaciones en Anestesiología y Reanimación. Barcelona: MCR; 2008. p. 49-78.